Over eighteen years Bob has gained market access experience in several consultancies including Bridgehead, PAREXEL, ICON, and HEOR. At PAREXEL Bob was head of US Market Access and in his most recent role, he led the Market Access team at HEOR. Bob has broad market access expertise across pricing, reimbursement, and HEOR, having led hundreds of projects providing access solutions for clients. He has supported a wide range of asset types and worked across global markets and in a broad range of therapeutic areas.
Before his consultancy career, Bob worked in the pharmaceutical and medical device sectors in UK and US-based roles, where he held positions in market access, commercial, clinical development, program management, and laboratory research.
Bob received his MBA from Warwick Business School, holds a postgraduate diploma in clinical research from Cardiff University, and gained his BSc Hons in Pharmacology from Leeds University. “I am delighted to join the talented and growing team at KMK,” said Bob on his appointment. “I look forward to working with our clients to provide access solutions and to help develop our market access capabilities which will be integrated with the current best-in-class business.”
KMK Consulting Inc.’s Global Market Access Principal, Stephen Deitch, added, “The Global Market Access team is very excited to welcome Bob. He brings complementary expertise in global market access and HEOR, both US and ex-US, as well as comprehensive experience across a broad range of pricing and market access engagements.”
With Bob at the helm, clients can confidently expect visionary solutions that will drive them to success. This perfectly reflects KMK’s commitment to improving services through dynamic partnerships and innovative strategies.